The intricate process of normal eye development, which occurs during the first trimester of pregnancy, involves several genes. When these genes make mistakes (called mutations), a serious eye condition can develop. Ophthalmic genetics is a much-needed and rapidly expanding field around the world. Ethnic variety, along with a high degree of consanguinity, has resulted in a global epidemic of genetic disorders. Inherited retinal disease (IRD) is the most common cause of blindness in people in their working years. Molecular diagnosis has been sped up thanks to advances in molecular genetic approaches, such as focused gene panel analysis and the use of next-generation sequencing methodologies. Likewise, developments in ocular imaging and visual function tests have enhanced our understanding of natural history, which is critical for evaluating treatment outcomes in clinical trials of potential IRD medicines.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Targeting immunological pathways in Behcet's uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom